Pfizer Inc.(NYSE: PFE) announced today that the Japanese Ministry of Health, Labour and Welfare approved Lyrica� (pregabalin) capsules for the treatment of peripheral neuropathic pain. This follows the recent approval in Japan of Lyrica for the treatment of postherpetic neuralgia on April 16, 2010. Lyrica is the first medication approved for peripheral neuropathic pain in Japan where it is co-promoted with Eisai Co., Ltd...
No comments:
Post a Comment